Human AI Teaming for Coronary CT Angiography Assessment: Impact on Imaging Workflow and Diagnostic Accuracy
-
Published:2023-11-30
Issue:23
Volume:13
Page:3574
-
ISSN:2075-4418
-
Container-title:Diagnostics
-
language:en
-
Short-container-title:Diagnostics
Author:
Andre Florian12ORCID, Fortner Philipp2, Aurich Matthias2ORCID, Seitz Sebastian2, Jatsch Ann-Kathrin2ORCID, Schöbinger Max3, Wels Michael3ORCID, Kraus Martin3, Gülsün Mehmet Akif4, Frey Norbert1, Sommer Andre2, Görich Johannes2, Buss Sebastian J.2
Affiliation:
1. Department of Cardiology, Angiology and Pneumology, University of Heidelberg, 69120 Heidelberg, Germany 2. MVZ DRZ Heidelberg, 69126 Heidelberg, Germany 3. Siemens Healthineers, 91301 Forchheim, Germany 4. Siemens Healthineers, Princeton, NJ 08540, USA
Abstract
As the number of coronary computed tomography angiography (CTA) examinations is expected to increase, technologies to optimize the imaging workflow are of great interest. The aim of this study was to investigate the potential of artificial intelligence (AI) to improve clinical workflow and diagnostic accuracy in high-volume cardiac imaging centers. A total of 120 patients (79 men; 62.4 (55.0–72.7) years; 26.7 (24.9–30.3) kg/m2) undergoing coronary CTA were randomly assigned to a standard or an AI-based (human AI) coronary analysis group. Severity of coronary artery disease was graded according to CAD-RADS. Initial reports were reviewed and changes were classified. Both groups were similar with regard to age, sex, body mass index, heart rate, Agatston score, and CAD-RADS. The time for coronary CTA assessment (142.5 (106.5–215.0) s vs. 195.0 (146.0–265.5) s; p < 0.002) and the total reporting time (274.0 (208.0–377.0) s vs. 350 (264.0–445.5) s; p < 0.02) were lower in the human AI than in the standard group. The number of cases with no, minor, or CAD-RADS relevant changes did not differ significantly between groups (52, 7, 1 vs. 50, 8, 2; p = 0.80). AI-based analysis significantly improves clinical workflow, even in a specialized high-volume setting, by reducing CTA analysis and overall reporting time without compromising diagnostic accuracy.
Funder
Siemens Healthcare, Forchheim, Germany
Subject
Clinical Biochemistry
Reference24 articles.
1. WHO (2023, May 24). The Top 10 Causes of Death. Available online: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. 2. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes;Knuuti;Eur. Heart J.,2020 3. National Institute for Health and Care Excellence (2016). Recent-Onset Chest Pain of Suspected Cardiac Origin: Assessment and Diagnosis, National Institute for Health and Care Excellence. 4. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Gulati;Circulation,2021 5. DISCHARGE Trial Group, Maurovich-Horvat, P., Bosserdt, M., Kofoed, K.F., Rieckmann, N., Benedek, T., Donnelly, P., Rodriguez-Palomares, J., Erglis, A., and Stechovsky, C. (2022). CT or Invasive Coronary Angiography in Stable Chest Pain. N. Engl. J. Med., 386, 1591–1602.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|